Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY)

CUSIP: 75943R102

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
4,389,099
Total 13F shares
85,493,244
Share change
-2,208,318
Total reported value
$2,955,555,198
Price per share
$34.57
Number of holders
135
Value change
-$171,240,328
Number of buys
91
Number of sells
32

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 75943R102?
CUSIP 75943R102 identifies RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of RLAY - Relay Therapeutics, Inc. - Common Stock, $0.01 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
SB INVESTMENT ADVISERS (UK) LTD
13F
Company
636%
27,904,963
$1,159,730,000 31 Dec 2020
13F
TRV GP III, LLC
13F
Company
240%
10,551,115
$438,504,000 31 Dec 2020
13F
FMR LLC
13F
Company
109%
4,762,238
$197,918,000 31 Dec 2020
13F
Casdin Capital, LLC
13F
Company
87%
3,808,894
$158,298,000 31 Dec 2020
13F
EcoR1 Capital, LLC
13F
Company
73%
3,200,649
$133,019,000 31 Dec 2020
13F
BlackRock Finance, Inc.
13F
Company
72%
3,156,974
$131,203,000 31 Dec 2020
13F
BVF INC/IL
13F
Company
70%
3,073,147
$127,720,000 31 Dec 2020
13F
TRV GP IV, LLC
13F
Company
64%
2,811,197
$116,833,000 31 Dec 2020
13F
PERCEPTIVE ADVISORS LLC
13F
Company
53%
2,329,407
$96,810,000 31 Dec 2020
13F
Foresite Capital Management IV, LLC
13F
Company
49%
2,139,380
$88,913,000 31 Dec 2020
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
47%
2,066,931
$85,902,000 31 Dec 2020
13F
Alphabet Inc.
13F
Company
41%
1,801,490
$74,870,000 31 Dec 2020
13F
VANGUARD GROUP INC
13F
Company
39%
1,720,675
$71,511,000 31 Dec 2020
13F
Bellevue Group AG
13F
Company
32%
1,409,357
$58,573,000 31 Dec 2020
13F
STATE STREET CORP
13F
Company
30%
1,326,705
$55,138,000 31 Dec 2020
13F
Boxer Capital, LLC
13F
Company
29%
1,294,132
$53,784,000 31 Dec 2020
13F
JPMORGAN CHASE & CO
13F
Company
29%
1,290,529
$53,633,000 31 Dec 2020
13F
DRIEHAUS CAPITAL MANAGEMENT LLC
13F
Company
25%
1,096,280
$45,561,000 31 Dec 2020
13F
RA CAPITAL MANAGEMENT, L.P.
13F
Company
23%
1,000,000
$41,560,000 31 Dec 2020
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
19%
820,769
$34,111,000 31 Dec 2020
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
18%
773,575
$32,150,000 31 Dec 2020
13F
GOLDMAN SACHS GROUP INC
13F
Company
16%
689,214
$28,644,000 31 Dec 2020
13F
FEDERATED HERMES, INC.
13F
Company
13%
568,309
$23,619,000 31 Dec 2020
13F
HARVARD MANAGEMENT CO INC
13F
Company
12%
541,124
$22,489,000 31 Dec 2020
13F
BESSEMER GROUP INC
13F
Company
12%
531,124
$22,074,000 31 Dec 2020
13F
Avoro Capital Advisors LLC
13F
Company
11%
500,000
$20,780,000 31 Dec 2020
13F
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
13F
Company
11%
484,395
$20,131,456 31 Dec 2020
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
10%
446,024
$18,536,000 31 Dec 2020
13F
Rock Springs Capital Management LP
13F
Company
9.4%
412,000
$17,123,000 31 Dec 2020
13F
Artal Group S.A.
13F
Company
9.1%
400,000
$16,624,000 31 Dec 2020
13F
Foresite Capital Management V, LLC
13F
Company
9.1%
400,000
$16,624,000 31 Dec 2020
13F
NORTHERN TRUST CORP
13F
Company
8.1%
355,893
$14,791,000 31 Dec 2020
13F
ORBIMED ADVISORS LLC
13F
Company
8%
350,000
$14,546,000 31 Dec 2020
13F
ArrowMark Colorado Holdings LLC
13F
Company
7.8%
340,277
$14,142,000 31 Dec 2020
13F
Woodline Partners LP
13F
Company
6.7%
293,215
$12,186,000 31 Dec 2020
13F
NORGES BANK
13F
Company
4.8%
209,085
$8,690,000 31 Dec 2020
13F
Fernwood Investment Management, LLC
13F
Company
3.8%
165,639
$6,884,000 31 Dec 2020
13F
Grace Capital
13F
Company
3.7%
164,389
$6,832,000 31 Dec 2020
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
3.6%
159,563
$6,632,000 31 Dec 2020
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
3.3%
143,531
$5,966,000 31 Dec 2020
13F
MOORE CAPITAL MANAGEMENT, LP
13F
Company
3%
130,162
$5,410,000 31 Dec 2020
13F
MORGAN STANLEY
13F
Company
2.9%
128,759
$5,351,000 31 Dec 2020
13F
Nuveen Asset Management, LLC
13F
Company
2.9%
128,691
$5,349,000 31 Dec 2020
13F
AMERICAN CENTURY COMPANIES INC
13F
Company
2.6%
116,275
$4,832,000 31 Dec 2020
13F
Bank of New York Mellon Corp
13F
Company
2.6%
115,854
$4,814,000 31 Dec 2020
13F
TCW GROUP INC
13F
Company
2.5%
108,142
$4,494,000 31 Dec 2020
13F
JANUS HENDERSON GROUP PLC
13F
Company
2.2%
98,092
$4,077,000 31 Dec 2020
13F
ICONIQ Capital, LLC
13F
Company
2.2%
94,697
$3,936,000 31 Dec 2020
13F
BAILLIE GIFFORD & CO
13F
Company
1.8%
79,932
$3,322,000 31 Dec 2020
13F
Ratan Capital Management LP
13F
Company
1.6%
70,000
$2,909,000 31 Dec 2020
13F

Institutional Holders of Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) as of Q1 2021

As of 31 Mar 2021, Relay Therapeutics, Inc. - Common Stock, $0.01 par value (RLAY) was held by 135 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 85,493,244 shares. The largest 10 holders included SB INVESTMENT ADVISERS (UK) LTD, FMR LLC, VANGUARD GROUP INC, BlackRock Inc., EcoR1 Capital, LLC, Casdin Capital, LLC, BVF INC/IL, DRIEHAUS CAPITAL MANAGEMENT LLC, Foresite Capital Management IV, LLC, and GILDER GAGNON HOWE & CO LLC. This page lists 135 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2021 vs Q4 2020 Across Filers

Q4 2020 holders
115
Q1 2021 holders
135
Holder diff
20
Investor Q4 2020 Shares Q1 2021 Shares Share Diff Share Chg % Q4 2020 Value $ Q1 2021 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.